BiotechTube
Home/Bioptamers/Emerson Moretto, M.Sc.
EM

Emerson Moretto, M.Sc.

CTO

Bioptamers

Therapeutic Areas

Oncology

Bioptamers Pipeline

DrugIndicationPhase
Aptamer-Drug Conjugate PlatformOncologyPre-clinical
Aptamer-Radionuclide Conjugate PlatformOncologyPre-clinical
Aptamer-Immunotherapy PlatformOncologyPre-clinical

Leadership Team at Bioptamers

EM
Erika Molina, Ph.D.
CEO
View full Bioptamers profile